Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
SGD Pharma is a global leader in glass pharmaceutical packaging.
SGD Pharma produces over 8 million vials and bottles per day at its 10 manufacturing plants in Europe and Asia. All plants are ISO 15378 certified.
With 9 sales offices and a wide distribution network, SGD Pharma offers a broad range of sizes and finishes in Type I, II, or III, amber and clear glass, as well as innovative added-value services like internal and external treatments or protective plastic coatings.
53
DitchCarbon score
Part of the Sustainability team at Sgd Pharma?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very High
Glass Container Manufacturing is among the most carbon-intensive industries
Industry performance
0.655
20182025
The Glass Container Manufacturing industry has reduced its overall emissions by 33% since 2018
Emissions trajectory 2020 – 2028
202020212022202320242025202620272028
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Sgd Pharma's reported carbon emissions
SGD Pharma, a French manufacturer in the rubber and plastic products industry, reported its 2025 emissions at approximately 477.5 million kg CO2e. This includes about 124.95 million kg CO2e from Scope 1 emissions, approximately 33.78 million kg CO2e from Scope 2 (market-based) emissions, and roughly 318.76 million kg CO2e from Scope 3 emissions.
For 2024, the company's total emissions were approximately 510.39 million kg CO2e, comprising around 121.55 million kg CO2e for Scope 1, approximately 59.91 million kg CO2e for Scope 2 (market-based), and roughly 328.93 million kg CO2e for Scope 3.
In 2023, SGD Pharma's total emissions were about 519.97 million kg CO2e, with Scope 1 emissions at approximately 138.08 million kg CO2e, Scope 2 (market-based) at roughly 61.60 million kg CO2e, and Scope 3 at about 320.29 million kg CO2e.
Looking at 2022, the total emissions were approximately 538.20 million kg CO2e, with Scope 1 emissions around 142.40 million kg CO2e, Scope 2 (market-based) at roughly 76.33 million kg CO2e, and Scope 3 at about 319.47 million kg CO2e.
The company has set several climate commitments. It aims for carbon neutrality by 2050. SGD Pharma also plans to reduce Scope 1 and 2 CO2 emissions by 35% by 2030 and by 65% by 2040, using a 2020 baseline for its plants in France, Germany, India, and China. Additionally, SGD Pharma is committed to a 42% reduction in its Scope 1 and 2 CO2 emissions by 2030, compared to 2022 levels, aligning with the 1.5°C climate threshold. The company is classified as "Committed" for near-term targets by the Science Based Targets initiative (SBTi).
Assessing Sgd Pharma as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Sgd Pharma and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Sgd Pharma’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Sgd Pharma24 days ago
53
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Frequently asked questions
Common questions about Sgd Pharma’s sustainability data and climate commitments
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more